RxDoctor Payments Data

Jamie Capal

Neurology with Special Qualifications in Child Neurology · Cincinnati, OHNPI 1366659310

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,467 of the $1,579 with a category attached, or 92.9%. Immedica Pharma US, Inc. accounts for 76.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $1,200 and has fallen 97.8% since, to $26 in 2025.

$1,579in general payments, 2019–2025

Across 8 payments — averaging $197.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Immedica Pharma US, Inc.$1K
  • Vertex$267
  • UCB, Inc.$55
  • Jazz Pharmaceuticals Inc.$31
  • Acadia Pharmaceuticals Inc$26
$848,742in research payments, 2019–2025

Across 41 payments — averaging $20,701 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$806K
  • Springworks Therapeutics, Inc.$42K

What the payments were for

  • Consulting fees$1,46793%
  • Food & beverage$1127%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,579 in reported general payments places this provider in the 55th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.

See all neurology with special qualifications in child neurology providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
Everolimus12$20,656

Paid to pharmacies, not to this prescriber.

Other neurology with special qualifications in child neurology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →